Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

Florida Cancer Specialists-Sarasota-61670, Tallahassee

Florida Cancer Specialists - East, West Palm Beach

Florida Cancer Specialists-Saint Petersburg-52979, St. Petersburg

Florida Cancer Specialists-Fort Myers-52980, Fort Myers

Tennessee Oncology, PLLC-Nashville-52568, Nashville

Tennessee Oncology, Chattanooga

Norton Cancer Institute, Louisville

Indiana University, Indianapolis

Medical College Of Wisconsin, Milwaukee

Oklahoma University School of Community Medicine, Oklahoma City

University of California San Diego, La Jolla

Cross Cancer Institute (University of Alberta), Edmonton

Princess Margaret Cancer Centre, Toronto

Beatson West of Scotland Cancer Centre, Glasgow

University College Hospital, London

Guy's Hospital, London

Sarah Cannon Research Institute-London-65253, London